MedTrace Logo

Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

NCT04518202 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-08-19

No results posted yet for this study

Summary

To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy

Conditions

  • Infertility, Female

Interventions

DRUG

lidocaine patch

5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.

DRUG

Sham patch

Sham patch containing no study medication applied at 6 hours before the scheduled office hysteroscopy.

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • nahla w Shady, md · Aswan universirty

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-08-31
Completion
2021-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04518202 on ClinicalTrials.gov